Robinul · DIN 02043610 · 0.2 mg/mL · injection solution
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2000-03-07 — choose a marketed DIN from the same-category list.Discontinued March 7, 2000 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2000-03-07 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2000-03-07 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 481
Reason for Use code 481
For the management of patients receiving palliative care*.
Coverage limit:
LU Authorization Period: 1 year
Coverage limit:
*The patient must have a progressive life-limiting illness and require this medication for palliative purposes.
1 brand, same coverage
Robinul · DIN 02043610
Manufacturer: Wyeth-Ayerst Canada Inc.; listing date 2015-03-31
Health Canada: Cancelled post market since 2000-03-07 · brand ROBINUL 0.2MG/ML LIQ INJ · ATC A03AB02 GLYCOPYRRONIUM · form Liquid · route Intravenous, Intramuscular · ingredients GLYCOPYRROLATE .2 MG/ML · company Wyeth-ayerst canada inc. · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product recordRobinul: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02043610)
Source record
DIN 02043610: Robinul
Raw flags: notABenefit=Y, sec3=Y
Item: 120808010; group id 214; item number 0388; lccId 00288; manufacturer id WYA
Source form: Inj Sol; strength: 0.2mg/mL
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02043610
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15891
Interchangeable products
Glycopyrrolate Injection · DIN 02382857 · $2.7825
Glycopyrrolate Injection USP · DIN 02473879 · $2.7825
Sandoz Glycopyrrolate · DIN 02039508 · $2.7825
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02043610
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since March 7, 2000 — choose a marketed DIN from the same-category list.